US Patent Issued to SIGILON THERAPEUTICS on Jan. 13 for "Compounds, devices, and uses thereof" (Texas, Massachusetts Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,571, issued on Jan. 13, was assigned to SIGILON THERAPEUTICS INC. (Cambridge, Mass.).

"Compounds, devices, and uses thereof" was invented by Omid Veiseh (Bellaire, Texas), Richard Heidebrecht (Somerville, Mass.), Paul Kevin Wotton (Boston), Matthias Alexander Oberli (Cambridge, Mass.) and Robert James Miller (East Bridgewater, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds, e.g., compounds of Formula (I) and pharmaceutically acceptable salts, solvates, hydrates, tautomers, stereoisomers, isotopically labeled derivatives, and compositions thereof. Also provided are implantable elements (e.g., devices and...